Website profile

Stat

Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.

  • 203articles · 30d
  • 9+ hour agolatest article
  • Aug 16, 2026earliest in window
  • 95%with images
  • 246avg words
articles per day
Categories
  • Medical 150
  • Health & Wellness 138
  • Health 100
  • Science & Technology 46
  • Business & Industrial 37
  • Economy, Business & Finance 22
  • Politics 19
  • Politics2 18

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

STAT
statnews.com > 09/10/2026 > readout-loud-podcast-heart-disease-drugs-failed-trials

Why two promising heart drugs flopped and what's next

3+ day, 14+ hour ago   (222+ words) By Adam Feuerstein, Elaine Chen, and Allison DeAngelis On this week’s episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease — but why did…...

STAT
statnews.com > 09/11/2026 > novartis-novo-nordisk-cardiovascular-drug-trials-fallout

Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field

3+ day, 8+ hour ago   (159+ words) The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines earlier this month. They could also have a chilling effect across the industry. Just before Labor Day, Novartis reported that its cardiac therapy, pelacarsen, failed in a…...

STAT
statnews.com > 09/10/2026 > roivant-biotech-dealmaking-mosliciguat-origins

Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon

3+ day, 21+ hour ago   (208+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...

STAT
statnews.com > 09/10/2026 > uniqure-huntingtons-gene-therapy-trial-readout

What to expect from UniQure's upcoming Huntington's gene therapy readout

3+ day, 21+ hour ago   (242+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...

STAT
statnews.com > 09/09/2026 > biotech-news-orexin-discovers-awawrded-prestigious-lasker-award

Orexin discoverers awarded prestigious Lasker award

4+ day, 18+ hour ago   (160+ words) By Elaine Chen and Allison DeAngelis First came the new teaser for Nathan Fielder’s documentary on Elizabeth Holmes. Now come the memes. Bring it on. For the past few months, key centers at the FDA have been led by acting…...

STAT
statnews.com > pharmalot > 09/09/2026 > astrazeneca-copd-win-fda-filling-key-jobs

Pharmalittle: We're reading about an AstraZeneca COPD win, the FDA filling key jobs, and more

4+ day, 19+ hour ago   (167+ words) Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. FDA names acting heads of drug and vaccine…...

STAT
statnews.com > 09/08/2026 > unitedhealth-campaign-donations-katherine-clark-no-surprises-act-debate

UnitedHealth’s Democrat investment, and surprise billing bloat debate

5+ day, 17+ hour ago   (136+ words) STAT I hope you all had a good Labor Day weekend. Robots may be able to run extremely fast now, but at least we know how to stop. Run your thoughts to me anytime: [email protected]. UnitedHealth Group’s top executives,…...

STAT
statnews.com > 09/08/2026 > roivant-mosliciguat-pulmonary-hypertension-interstitial-lung-disease-results

Roivant lung disease drug hits mid-stage study goals

5+ day, 22+ hour ago   (242+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...

STAT
statnews.com > 09/08/2026 > novartis-del-desiran-myotonic-dystrophy-harbor-trial-failure-neuromuscular

Neuromuscular drug from Novartis fails in key study, adding to pressure on company

6+ day, 55+ min ago   (153+ words) An experimental drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study, Novartis said Tuesday, the company’s second major trial collapse in a matter of days. The two study flops will likely raise questions about…...

STAT
statnews.com > 09/04/2026 > angelman-syndrome-drug-ultragenyx-oak-hill-ionis

After failure of Angelman syndrome drug, experts see hope in other experimental therapies

1+ week, 2+ day ago   (205+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...